ORTHOCELL LIMITED — Director's Dealing 2023

Nov 6, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity	Orthocell Limited
ABN	57 118 897 135

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

director for the purposes of section	205G of the Corporations Act.
Name of Director	Paul Anderson
Date of last notice	16 June 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving riseto the relevant interest.	Mr Anderson is a trustee and beneficiary of the ElwingSuperannuation FundNicole Telford – spouse
Date of change	7 November 2023
No. of securities held prior tochangePaul Anderson & Nicole TelfordPaul AndersonNicole TelfordPaul Anderson & Nicole Telford	6,233,335 Ordinary Shares16 Ordinary Shares4,000,000 Unlisted Options exercisable at $0.583 expiring 14October 20241,200,000 Unlisted Options exercisable at $0.583 expiring 14October 2024670,454 Ordinary Shares
Class	Unlisted Options exercisable at $0.36 expiring 7 November2027
Number acquired	500,000
Number disposed	-
Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation	Nil

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change
Paul Anderson and Nicole Telford	6,233,335 Ordinary Shares
Paul Anderson	16 Ordinary Shares
	4,000,000 Unlisted Options exercisable at $0.583 expiring 14
	October 2024
Nicole Telford	1,200,000 Unlisted Options exercisable at $0.583 expiring 14
	October 2024
	500,000 Unlisted Options exercisable at $0.36 expiring 7
	November 2023
Paul Anderson and Nicole Telford	670,454 Ordinary Shares
Nature of change	Issue of options to Nicole Telford following shareholder
Example: on-market trade, off-market trade, exerciseof options, issue of securities under dividendreinvestment plan, participation in buy-back	approval at the Annual General Meeting held on 31 October2023.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

disclosed in this part.
Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which interest related prior to	N/A
change
Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change	N/A

Part 3 Closed Period

Part 3 Closed Period
Were the interests in the securities or contracts detailed above traded	No
during a +closed period where prior written clearance was required?
If so, was prior written clearance provided to allow the trade to proceed	N/A
during this period?
If prior written clearance was provided, on what date was this	N/A
provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2